← Leaderboards
Kenneth K Chan
La Biomed Res Inst/ Harbor Ucla Med Ctr
$1,473,754
Attributed
$2,093,973
Total exposure
6
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $442.8K · FY2011–15$500K$375K$250K$125K$0
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$2,093,973 · 6
By mechanism
R01$930,328 · 1
P30$492,383 · 1
M01$476,938 · 2
N01$194,324 · 2
Top collaborators
- Guido Marcucci3 shared
- Natarajan Muthusamy3 shared
Others in their field
Top investigators on “Method Development”
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$370,834,572
- Richard K. Wilson · Washington University$345,937,296
- Richard A Gibbs · Baylor College Of Medicine$329,093,388
- Lawrence Corey · Fred Hutchinson Cancer Center$318,434,103
- George R Seage · Abt Associates, Inc.$292,142,010
- Eric S Lander · Whitehead Institute For Biomedical Res$262,517,055
Research focus
Method DevelopmentAnalytical MethodPlasmaValidationClinical ResearchHuman SubjectDrug KineticsDesignPre-ClinicalToxic EffectDoseScheduleBiologicalPharmacodynamicsPharmaceutical PreparationsBirthBiological AvailabilityAntineoplastic AgentsAntiaids AgentCancer Center Support GrantComprehensive Cancer CenterData AnalysesArea Under CurveClinical Trials
Grant awards (17)
Pharmacoanalytical$125,260
P30 · FY2015 · CA · contact PI
Pharmacoanalytical$122,584
P30 · FY2014 · CA · contact PI
Validation of microRNAs as therapeutic targets in hematological malignancies$297,452
R01 · FY2013 · CA
Pharmacoanalytical$118,161
P30 · FY2013 · CA · contact PI
Validation of microRNAs as therapeutic targets in hematological malignancies$316,438
R01 · FY2012 · CA
Pharmacoanalytical$126,378
P30 · FY2012 · CA · contact PI
Validation of microRNAs as therapeutic targets in hematological malignancies$316,438
R01 · FY2011 · CA
REGULATORY ROLE OF CALCITONIN GENE RELATED PEPTIDE$237,978
M01 · FY2001 · RR
DIURNAL VERSUS NOCTURNAL INDUCTION OF LABOR$237,978
M01 · FY2001 · RR
PRECLINICAL PHARMACOLOGICAL STUDIES OF ANTITUMOR AND ANT$155,168
N01 · FY2000 · CM
PRECLINICAL PHARMACOLOGICAL STUDIES OF ANTITUMOR AND ANT$31,034
N01 · FY2000 · CM
PRECLINICAL PHARMACOLOGICAL STUDIES$8,122
N01 · FY2000 · CM
REGULATORY ROLE OF CALCITONIN GENE RELATED PEPTIDE$982
M01 · FY2000 · RR
PRECLINICAL PHARMACOLOGICAL STUDIES OF ANTITUMOR AND ANT$0
N01 · FY2000 · CM
DIURNAL VERSUS NOCTURNAL INDUCTION OF LABOR$0
M01 · FY2000 · RR
DIURNAL VERSUS NOCTURNAL INDUCTION OF LABOR$0
M01 · FY2000 · RR
DIURNAL VERSUS NOCTURNAL INDUCTION OF LABOR$0
M01 · FY2000 · RR